Felix Hohendanner

1.0k total citations
42 papers, 696 citations indexed

About

Felix Hohendanner is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Felix Hohendanner has authored 42 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Felix Hohendanner's work include Cardiac electrophysiology and arrhythmias (23 papers), Cardiovascular Function and Risk Factors (14 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Felix Hohendanner is often cited by papers focused on Cardiac electrophysiology and arrhythmias (23 papers), Cardiovascular Function and Risk Factors (14 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Felix Hohendanner collaborates with scholars based in Germany, United States and Austria. Felix Hohendanner's co-authors include Frank R. Heinzel, Burkert Pieske, Lothar A. Blatter, Simon Sedej, Frank Edelmann, Ge Jin, Abdul Shokor Parwani, Florian Blaschke, Joshua T. Maxwell and David Bode and has published in prestigious journals such as PLoS ONE, Circulation Research and The Journal of Physiology.

In The Last Decade

Felix Hohendanner

37 papers receiving 686 citations

Peers

Felix Hohendanner
Ilona Cuijpers Netherlands
U Keller Germany
O BING United States
Yoko Eto Japan
Domenico M. Taglieri United States
Outi Villet United States
Janice M. Pfeffer United States
Linda B. Stull United States
Felix Hohendanner
Citations per year, relative to Felix Hohendanner Felix Hohendanner (= 1×) peers Paulina Wakula

Countries citing papers authored by Felix Hohendanner

Since Specialization
Citations

This map shows the geographic impact of Felix Hohendanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Hohendanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Hohendanner more than expected).

Fields of papers citing papers by Felix Hohendanner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Hohendanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Hohendanner. The network helps show where Felix Hohendanner may publish in the future.

Co-authorship network of co-authors of Felix Hohendanner

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Hohendanner. A scholar is included among the top collaborators of Felix Hohendanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Hohendanner. Felix Hohendanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Primeßnig, Uwe, Timo Z. Nazari‐Shafti, Herko Grubitzsch, et al.. (2025). Structural and functional adaptations of human cardiomyocytes in metabolic disease and heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 328(6). H1193–H1203.
2.
Gerds‐Li, Jin‐Hong, et al.. (2025). Simultaneous atrial fibrillation and sinus rhythm in a heart transplant recipient: ablation guided by novel dispersion analysis: a case report. European Heart Journal - Case Reports. 9(4). ytaf152–ytaf152. 1 indexed citations
3.
Hohendanner, Felix, Kun Zhang, Stephan Dreysse, et al.. (2024). Microvascular dysfunction in heart transplantation is associated with altered cardiomyocyte mitochondrial structure and unimpaired excitation-contraction coupling. PLoS ONE. 19(5). e0303540–e0303540. 1 indexed citations
4.
Solowjowa, Natalia, Michael Dandel, Jan Knierim, et al.. (2024). Left ventricular diastolic function assessed by speckle tracking echocardiography in patients with left ventricular aneurysm. The International Journal of Cardiovascular Imaging. 40(10). 2087–2101.
5.
Hohendanner, Felix, Sebastian Scholz, Volkmar Falk, et al.. (2023). Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure. Frontiers in Physiology. 14. 1086730–1086730. 2 indexed citations
6.
7.
Hohendanner, Felix, Nicola Wilck, Verena Stangl, et al.. (2023). Gq-Mediated Arrhythmogenic Signaling Promotes Atrial Fibrillation. Biomedicines. 11(2). 526–526. 1 indexed citations
8.
Bode, David, Christian U. Oeing, Alessio Alogna, et al.. (2021). Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation. International Journal of Molecular Sciences. 22(11). 5937–5937. 9 indexed citations
9.
Primeßnig, Uwe, David Bode, Paulina Wakula, et al.. (2021). Right-Ventricular Dysfunction in HFpEF is Linked to Altered Cardiomyocyte Ca2+ Homeostasis and Myofilament Sensitivity. ESC Heart Failure. 8(4). 3130–3144. 13 indexed citations
10.
Stachelscheid, Harald, Florian Blaschke, Jan Matthias Kruse, et al.. (2021). COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab. PLoS ONE. 16(8). e0255976–e0255976. 14 indexed citations
11.
Bode, David, Paulina Wakula, Uwe Primeßnig, et al.. (2021). Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF. Cardiovascular Diabetology. 20(1). 7–7. 89 indexed citations
12.
Bode, David, Natale Rolim, Paulina Wakula, et al.. (2021). Effects of Different Exercise Modalities on Cardiac Dysfunction in Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 8(3). 1806–1818. 7 indexed citations
13.
Blaschke, Florian, Abdul Shokor Parwani, Felix Hohendanner, et al.. (2021). Wearable Cardioverter-Defibrillator: Friend or Foe in Suspected Myocarditis?. ESC Heart Failure. 8(4). 2591–2596. 6 indexed citations
14.
Heinzel, Frank R., Abdul Shokor Parwani, Felix Hohendanner, et al.. (2021). Magnetic field–induced interactions between phones containing magnets and cardiovascular implantable electronic devices: Flip it to be safe?. Heart Rhythm. 19(3). 372–380. 11 indexed citations
15.
Parwani, Abdul Shokor, Felix Hohendanner, Frank R. Heinzel, et al.. (2020). Are Contemporary Smartwatches and Mobile Phones Safe for Patients With Cardiovascular Implantable Electronic Devices?. JACC. Clinical electrophysiology. 6(9). 1158–1166. 18 indexed citations
16.
Morris, Daniel A., Abdul Shokor Parwani, Wolfram Doehner, et al.. (2020). The Effect of Iron Deficiency on Cardiac Resynchronization Therapy: Results from the RIDE-CRT Study. ESC Heart Failure. 7(3). 1072–1084. 12 indexed citations
17.
Hohendanner, Felix, David Bode, Uwe Primeßnig, et al.. (2017). Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF. Journal of Molecular and Cellular Cardiology. 115. 10–19. 25 indexed citations
18.
Hohendanner, Felix, Frank R. Heinzel, Florian Blaschke, et al.. (2017). Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. Heart Failure Reviews. 23(1). 27–36. 39 indexed citations
19.
Heinzel, Frank R., Felix Hohendanner, Ge Jin, Simon Sedej, & Frank Edelmann. (2015). Myocardial hypertrophy and its role in heart failure with preserved ejection fraction. Journal of Applied Physiology. 119(10). 1233–1242. 112 indexed citations
20.
Hohendanner, Felix, Senka Ljubojević-Holzer, Niall Macquaide, et al.. (2013). Intracellular Dyssynchrony of Diastolic Cytosolic [Ca 2+ ] Decay in Ventricular Cardiomyocytes in Cardiac Remodeling and Human Heart Failure. Circulation Research. 113(5). 527–538. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026